Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg
Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan modafinil 200 mg
tablets to Cephalon Provigil® 200 mg tablets following a single, oral 200 mg (1 x 200 mg)
dose administration under fasting conditions.